Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol
Clinical trial NCT01760252 · TERMINATED
Trial details
- NCT number
- NCT01760252
- Sponsor
- Beth Israel Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2018-02-21
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.